David Eilender Selected Research

4,4'- dihydroxybenzophenone- 2,4- dinitrophenylhydrazone

6/2006

4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Eilender Research Topics

Disease

2	Colonic Neoplasms (Colon Cancer) 01/2018 - 05/2011
2	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2006
2	Neoplasm Micrometastasis 01/2018 - 05/2011
2	Neoplasms (Cancer) 06/2006 - 01/2002
1	Hemangiosarcoma (Angiosarcoma) 06/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2006
1	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2006
1	B-Cell Leukemia (Leukemia, B Cell) 11/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2003
1	Acute Promyelocytic Leukemia 11/2003
1	Leukemia 11/2003

Drug/Important Bio-Agent (IBA)

1	Coloring Agents (Dyes)IBA 01/2018
1	4,4'- dihydroxybenzophenone- 2,4- dinitrophenylhydrazoneIBA 06/2006
1	4- (3- (1- adamantyl)- 4- hydroxyphenyl)- 3- chlorocinnamic acidIBA 11/2003
1	RetinoidsIBA 11/2003
1	CD 437IBA 11/2003
1	bcl-X ProteinIBA 11/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2003
1	AcidsIBA 11/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2018 - 05/2011
1	Adjuvant Chemotherapy 01/2018
1	Palliative Care (Palliative Therapy) 06/2006
1	Radiotherapy 06/2006
1	Therapeutics 01/2002